Breast Diagnostic Pathology Handbook

This reference is built for the pathologist who has to separate usual hyperplasia from atypia, a benign fibroepithelial lesion from phyllodes tumor, or artifact from malignancy under time pressure, and defend that call in the report. It moves from the histology of the normal terminal duct lobular unit and preanalytic fixation standards through the full proliferative and neoplastic spectrum, into receptor and molecular testing, and out to axillary staging and intraoperative consultation, tying each diagnostic line to the criterion that actually separates it from its nearest mimic. Every major decision point is built around The Atypia Threshold System, a five-part clinical-decision framework, the lesion, the threshold criterion, concordance with imaging, the trap that misleads, and the anchor finding that locks the call, embedded throughout the text and consolidated in The Breast Diagnostic Threshold Atlas, a fifty-eight-entry indexed reference cross-mapped by immunohistochemical profile and imaging correlate. At the Bench, This Reference Will Help You - Separate usual ductal hyperplasia from atypical ductal hyperplasia - architectural and cytologic criteria that resolve the field's most consequential borderline call. - Lock ductal carcinoma in situ margins and grade - the ink-on-tumor standard and comedo-necrosis criteria that determine re-excision. - Distinguish lobular neoplasia from its ductal mimics - E-cadherin and p120 reasoning for ALH, LCIS, and pleomorphic LCIS. - Interpret HER2 and hormone receptor results at the equivocal margin - reflex-testing thresholds and low-positive reporting standards. - Read neoadjuvant response and axillary nodal status - pCR criteria and Z0011-directed micrometastasis versus macrometastasis calls. - Grade phyllodes tumors and…